Trial intelligence / Profile preview

Effect of Sarpogrelate on Spinal Stenosis

KCT0003795Phase 4Completed

Sponsor
Daewoong Pharmaceutical
Start
Feb 2019
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of sarpogrelate in spinal stenosis, sponsored by Daewoong Pharmaceutical. Started Feb 2019; status: completed.

02

Drugs

sarpogrelate
03

Conditions

spinal stenosis

Beyond the preview

Go deeper on KCT0003795.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on KCT0003795.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call